Dhanuka Agritech Community

BSE:507717 Community

1 Narratives written by author
0 Comments on narratives written by author
6 Fair Values set on narratives written by author

Dhanuka Agritech

AN

AnalystConsensusTarget

Consensus Narrative from 8 Analysts

Acquisition Of Iprovalicarb And Triadimenol Will Expand Reach Into Over 20 New Countries

Key Takeaways Focus on novel chemistry and product development with strategic acquisitions could drive revenue growth through expanded market reach and diversified revenue streams. International expansion, leveraging cost advantages, and strengthened R&D initiatives may improve net margins and future earnings growth through high-margin sales and innovation.

₹1.74k

FV

20.1% undervalued

16.13%

Revenue growth p.a.

0

0

5

7 days ago